/Merck%20%26%20Co%20Inc%20logo%20and%20pill-by%20viewimage%20via%20Shutterstock.jpg)
Rahway, New Jersey-based Merck & Co., Inc. (MRK) is an international healthcare company that offers human health pharmaceuticals across various areas, including Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, and other brands. Valued at a market cap of $304.5 billion, the company is expected to release its Q1 2026 earnings on Thursday, Apr. 30, before the market opens.
Ahead of the event, analysts expect the company’s loss per share to be $0.58 on a diluted basis, down 126.1% from $2.22 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.